Encompass Health (EHC) Releases Earnings Results, Beats Expectations By $0.01 EPS

Encompass Health (AMEX:EHC) released its earnings results on Thursday. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.79 by $0.01, Briefing.com reports. The company had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.09 billion. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.70 EPS. Encompass Health updated its FY 2019 guidance to $3.71-3.85 EPS and its FY19 guidance to $3.71-3.85 EPS.

Encompass Health has a 52-week low of $40.86 and a 52-week high of $59.29.

A number of institutional investors and hedge funds have recently bought and sold shares of EHC. Harvest Fund Management Co. Ltd boosted its holdings in Encompass Health by 72.1% in the 3rd quarter. Harvest Fund Management Co. Ltd now owns 2,714 shares of the company’s stock valued at $212,000 after purchasing an additional 1,137 shares during the last quarter. Thrivent Financial for Lutherans boosted its holdings in Encompass Health by 5.8% in the 3rd quarter. Thrivent Financial for Lutherans now owns 23,833 shares of the company’s stock valued at $1,858,000 after purchasing an additional 1,317 shares during the last quarter. IFP Advisors Inc boosted its holdings in Encompass Health by 696.3% in the 3rd quarter. IFP Advisors Inc now owns 1,521 shares of the company’s stock valued at $119,000 after purchasing an additional 1,330 shares during the last quarter. Koshinski Asset Management Inc. boosted its holdings in Encompass Health by 35.0% in the 3rd quarter. Koshinski Asset Management Inc. now owns 5,135 shares of the company’s stock valued at $400,000 after purchasing an additional 1,330 shares during the last quarter. Finally, US Bancorp DE boosted its holdings in Encompass Health by 11.5% in the 3rd quarter. US Bancorp DE now owns 13,858 shares of the company’s stock valued at $1,081,000 after purchasing an additional 1,428 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.



A number of research firms have recently commented on EHC. Zacks Investment Research cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Wednesday, January 9th. Jefferies Financial Group began coverage on shares of Encompass Health in a research note on Thursday, December 20th. They set a “buy” rating for the company. Barclays began coverage on shares of Encompass Health in a research note on Friday, December 14th. They set an “equal weight” rating and a $75.00 target price for the company. Finally, UBS Group began coverage on shares of Encompass Health in a research note on Thursday, November 15th. They set a “buy” rating and a $86.00 target price for the company. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $72.82.

ILLEGAL ACTIVITY WARNING: “Encompass Health (EHC) Releases Earnings Results, Beats Expectations By $0.01 EPS” was posted by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://dakotafinancialnews.com/2019/02/08/encompass-health-ehc-releases-earnings-results-beats-expectations-by-0-01-eps.html.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Recommended Story: Stock Split

Earnings History for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply